These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16251229)

  • 1. Efficacy of drug eluting stents in patients with and without diabetes mellitus: indirect comparison of controlled trials.
    Stettler C; Allemann S; Egger M; Windecker S; Meier B; Diem P
    Heart; 2006 May; 92(5):650-7. PubMed ID: 16251229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug eluting stents: an updated meta-analysis of randomised controlled trials.
    Roiron C; Sanchez P; Bouzamondo A; Lechat P; Montalescot G
    Heart; 2006 May; 92(5):641-9. PubMed ID: 16216853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug eluting and bare metal stents in people with and without diabetes: collaborative network meta-analysis.
    Stettler C; Allemann S; Wandel S; Kastrati A; Morice MC; Schömig A; Pfisterer ME; Stone GW; Leon MB; de Lezo JS; Goy JJ; Park SJ; Sabaté M; Suttorp MJ; Kelbaek H; Spaulding C; Menichelli M; Vermeersch P; Dirksen MT; Cervinka P; De Carlo M; Erglis A; Chechi T; Ortolani P; Schalij MJ; Diem P; Meier B; Windecker S; Jüni P
    BMJ; 2008 Aug; 337():a1331. PubMed ID: 18757996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients.
    Dibra A; Kastrati A; Mehilli J; Pache J; Schühlen H; von Beckerath N; Ulm K; Wessely R; Dirschinger J; Schömig A;
    N Engl J Med; 2005 Aug; 353(7):663-70. PubMed ID: 16105990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
    Stone GW; Moses JW; Ellis SG; Schofer J; Dawkins KD; Morice MC; Colombo A; Schampaert E; Grube E; Kirtane AJ; Cutlip DE; Fahy M; Pocock SJ; Mehran R; Leon MB
    N Engl J Med; 2007 Mar; 356(10):998-1008. PubMed ID: 17296824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease.
    Shafiq N; Malhotra S; Pandhi P; Grover A; Uboweja A
    Br J Clin Pharmacol; 2005 Jan; 59(1):94-101. PubMed ID: 15606446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents.
    Babapulle MN; Joseph L; Bélisle P; Brophy JM; Eisenberg MJ
    Lancet; 2004 Aug 14-20; 364(9434):583-91. PubMed ID: 15313358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization.
    Windecker S; Remondino A; Eberli FR; Jüni P; Räber L; Wenaweser P; Togni M; Billinger M; Tüller D; Seiler C; Roffi M; Corti R; Sütsch G; Maier W; Lüscher T; Hess OM; Egger M; Meier B
    N Engl J Med; 2005 Aug; 353(7):653-62. PubMed ID: 16105989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sirolimus versus paclitaxel eluting stents for treatment of coronary in-stent restenosis.
    Airoldi F; Briguori C; Iakovou I; Stankovic G; Biondi-Zoccai G; Carlino M; Chieffo A; Montorfano M; Cosgrave J; Michev I; Rogacka R; Sangiorgi GM; Colombo A
    Am J Cardiol; 2006 Apr; 97(8):1182-7. PubMed ID: 16616023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sirolimus- or paclitaxel-eluting stents to prevent coronary artery restenosis.
    Doggrell SA
    Expert Opin Pharmacother; 2004 Nov; 5(11):2209-20. PubMed ID: 15500367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stent thrombosis in randomized clinical trials of drug-eluting stents.
    Mauri L; Hsieh WH; Massaro JM; Ho KK; D'Agostino R; Cutlip DE
    N Engl J Med; 2007 Mar; 356(10):1020-9. PubMed ID: 17296821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.
    Stettler C; Wandel S; Allemann S; Kastrati A; Morice MC; Schömig A; Pfisterer ME; Stone GW; Leon MB; de Lezo JS; Goy JJ; Park SJ; Sabaté M; Suttorp MJ; Kelbaek H; Spaulding C; Menichelli M; Vermeersch P; Dirksen MT; Cervinka P; Petronio AS; Nordmann AJ; Diem P; Meier B; Zwahlen M; Reichenbach S; Trelle S; Windecker S; Jüni P
    Lancet; 2007 Sep; 370(9591):937-48. PubMed ID: 17869634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A meta-analysis of trials comparing Cypher and Taxus stents in patients with obstructive coronary artery disease.
    Sidhu S; Shafiq N; Malhotra S; Pandhi P; Grover A
    Br J Clin Pharmacol; 2006 Jun; 61(6):720-6. PubMed ID: 16722835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zotarolimus-eluting stent versus sirolimus-eluting and paclitaxel-eluting stents for percutaneous coronary intervention: a meta-analysis of randomized trials.
    Sethi A; Bahekar A; Bhuriya R; Bajaj A; Singh PP; Arora R; Khosla S
    Arch Cardiovasc Dis; 2012 Nov; 105(11):544-56. PubMed ID: 23177483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus-eluting stents vs paclitaxel-eluting stents in patients with coronary artery disease: meta-analysis of randomized trials.
    Kastrati A; Dibra A; Eberle S; Mehilli J; Suárez de Lezo J; Goy JJ; Ulm K; Schömig A
    JAMA; 2005 Aug; 294(7):819-25. PubMed ID: 16106007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of everolimus-eluting stent versus sirolimus-eluting stent implantation for de novo coronary artery disease in patients with diabetes mellitus (ESSENCE-DIABETES): results from the ESSENCE-DIABETES trial.
    Kim WJ; Lee SW; Park SW; Kim YH; Yun SC; Lee JY; Park DW; Kang SJ; Lee CW; Lee JH; Choi SW; Seong IW; Lee BK; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Park WJ; Kim HS; Chae JK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Choi YJ; Cheong SS; Yang TH; Jang JS; Her SH; Park SJ;
    Circulation; 2011 Aug; 124(8):886-92. PubMed ID: 21810659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
    Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
    Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.